Effect of Pioglitazone on Thyroid Hormones and IGF-I in Patients with Type 2 Diabetes

Lisa Arnetz^1*, Mikael Lantz², Kerstin Brismar¹, Neda Rajamand Ekberg¹, Michael Alvarsson¹ and Mozhgan Dorkhan²

¹Department of Molecular Medicine and Surgery, Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden

²Department of Clinical Sciences, Division of Diabetes & Endocrinology, Lund University, Malmo University Hospital, Sweden

^*Corresponding Author: Lisa Arnetz, Department of Molecular Medicine and Surgery, Karolinska Institutet D2:04 Karolinska University Hospital, 17176 Stockholm, Sweden, Tel: 08-524 800 00 Email: